Structure of a cannabinoid receptor and functional expression of the cloned cDNA
The DOI matches its Crossref record; 19 of the 20 references it cites were found in a registry or an index.
Abstract
Marijuana and many of its constituent cannabinoids influence the central nervous system (CNS) in a complex and dose-dependent manner. Although CNS depression and analgesia are well documented effects of the cannabinoids, the mechanisms responsible for these and other cannabinoid-induced effects are not so far known. The hydrophobic nature of these substances has suggested that cannabinoids resemble anaesthetic agents in their action, that is, they nonspecifically disrupt cellular membranes. Recent evidence, however, has supported a mechanism involving a G protein-coupled receptor found in brain and neural cell lines, and which inhibits adenylate cyclase activity in a dose-dependent, stereoselective and pertussis toxin-sensitive manner. Also, the receptor is more responsive to psychoactive cannabinoids than to non-psychoactive cannabinoids. Here we report the cloning and expression of a complementary DNA that encodes a G protein-coupled receptor with all of these properties. Its messenger RNA is found in cell lines and regions of the brain that have cannabinoid receptors. These findings suggest that this protein is involved in cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The primary psychoactive constituent of cannabis, THC (Mechoulam and Gaoni, 1965), and certain other plant-derived or synthetic psychoactive cannabinoids bind cannabinoid (CB 1 and CB 2 ) receptors (Devane et al, 1988;Matsuda et al, 1990;Munro et al, 1993).”
From The endogenous cannabinoid system: a budding source of targets for treating inflammatory and neuropathic pain (2018) · cites this paper as Matsuda et al, 1990
In the citing paper
“Cannabinoids, like many analgesics and recreational drugs, act on the brain’s reward pathways. Cannabinoid-1 receptors (CB1R) are co-localized with the opioid receptors on the dopaminergic cells of the nucleus accumbens, probably the most important structure in human reward pathways, which partly overlaps the antinociceptive pathways [30–32].”
From Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial (2012) · cites this paper as [30]
In the citing paper
“Both CB12 and CB23 receptors are G-coupled protein receptors that are negatively coupled to adenylate cyclase.”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [2]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
High-efficiency transformation of mammalian cells by plasmid DNA.
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,373
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
G proteins and dual control of adenylate cyclase
Gilman, A. G. (1984) · Cell · doi:10.1016/0092-8674(84)90336-2 · Cited by 1,802
Identification of a Family of Muscarinic Acetylcholine Receptor Genes
Bonner, T. I., Buckley, N. J., Young, A. C., & Brann, M. R. (1987) · Science · doi:10.1126/science.3037705 · Cited by 1,427
Self-citationA cDNA cloning vector that permits expression of cDNA inserts in mammalian cells.
Okayama, H., & Berg, P. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.2.280 · Cited by 933
Lutropin-Choriogonadotropin Receptor: An Unusual Member of the G Protein-Coupled Receptor Family
McFarland, K. C., Sprengel, R., Phillips, H. S., Köhler, M., Rosemblit, N., Nikolics, K., Segaloff, D. L., & Seeburg, P. H. (1989) · Science · doi:10.1126/science.2502842 · Cited by 929
Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain.
Young, W. S., Bonner, T. I., & Brann, M. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.24.9827 · Cited by 743
Self-citationcDNA eloping of bovine substance-K receptor through oocyte expression system
Masu, Y., Nakayama, K., Tamaki, H., Harada, Y., Kuno, M., & Nakanishi, S. (1987) · Nature · doi:10.1038/329836a0 · Cited by 742
Cloning and Sequencing of Porcine LH-hCG Receptor cDNA: Variants Lacking Transmembrane Domain
Loosfelt, H., Misrahi, M., Atger, M., Salesse, R., Vu Hai-Luu Thi, M. T., Jolivet, A., Guiochon-Mantel, A., Sar, S., Jallal, B., Garnier, J., et al. (1989) · Science · doi:10.1126/science.2502844 · Cited by 559
Research works printed but not linked: 14
- Hollister, L. E. Pharmac. Rev. 38, 1–20 (1986).
- Martin, B. R. Pharmac. Rev. 38, 45–74 (1986).
- Dewey, W. L. Pharmac. Rev. 38, 151–178 (1986).
- Howlett, A. C. Molec. Pharmacol. 27, 429–436 (1985).
- Howlett, A. C. & Fleming, R. M. Molec. Pharmacol. 26, 532–538 (1984).
- Howlett, A. C., Qualy, J. M. & Khachatrian, L. L. Molec. Pharmacol. 29, 307–313 (1986).
- Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S. & Howlett, A. C. Molec. Pharmacol. 34, 605–613 (1988).
- Howlett, A. C., Johnson, M. R., Melvin, L. S. & Milne, G. M. Molec. Pharmacol. 33, 297–302 (1988).
- Razdan, R. K. Pharmac. Rev. 38, 75–149 (1986).
- Lawrence, D. K. & Gill, E. W. Molec. Pharmacol. 11, 595–602 (1975).
- Hillard, C. J., Harris, R. A. & Bloom, A. S. J. Pharmac. exp. Ther. 232, 579–588 (1985).
- Okayama, H. & Berg, P. Molec. cell. Biol. 3, 280–289 (1983).
- Chen, C. & Okayama, H. Molec. cell. Biol. 7, 2745–2752 (1987).
- Brooker, G., Harper, J. F., Terasaki, W. L. & Moylan, R. D. Adv. Cyclic Nucleotide Res. 10, 1–33 (1979).
Cited by
Items 701–800 of 1,050
Prenatal cannabis exposure - The “first hit” to the endocannabinoid system
Richardson, K. A., Hester, A. K., & McLemore, G. L. (2016) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2016.08.003 · Cited by 157
From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis
Mechoulam, R., & Ben-Shabat, S. (1999) · Natural Product Reports · doi:10.1039/a703973e · Cited by 138
A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain
Ong, W.-Y., & Mackie, K. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00025-1 · Cited by 161
Basavarajappa, B. S., & Hungund, B. L. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720522.x · Cited by 146
Stress regulates endocannabinoid-CB1 receptor signaling
Hillard, C. J. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.04.001 · Cited by 137
The Endocannabinoid Signaling System in the CNS
Hillard, C. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.10.001 · Cited by 136
New Insights in Cannabinoid Receptor Structure and Signaling
Ye, L., Cao, Z., Wang, W., & Zhou, N. (2019) · Current Molecular Pharmacology · doi:10.2174/1874467212666190215112036 · Cited by 155
Mathison, R., Ho, W., Pittman, Q. J., Davison, J. S., & Sharkey, K. A. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705889 · Cited by 141
Evidence that anandamide‐signaling regulates human sperm functions required for fertilization
Schuel, H., Burkman, L. J., Lippes, J., Crickard, K., Mahony, M. C., Giuffrida, A., Picone, R. P., & Makriyannis, A. (2002) · Molecular Reproduction and Development · doi:10.1002/mrd.90021 · Cited by 146
The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat
Price, T. J., Helesic, G., Parghi, D., Hargreaves, K., & Flores, C. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00333-6 · Cited by 144
Sugiura, T., Kodaka, T., Nakane, S., Kishimoto, S., Kondo, S., & Waku, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8187 · Cited by 160
Endocannabinoids in Synaptic Plasticity and Neuroprotection
Xu, J.-Y., & Chen, C. (2015) · The Neuroscientist · doi:10.1177/1073858414524632 · Cited by 135
Neuronal substrates and functional consequences of prenatal cannabis exposure
Calvigioni, D., Hurd, Y. L., Harkany, T., & Keimpema, E. (2014) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-014-0550-y · Cited by 154
Lafenêtre, P., Chaouloff, F., & Marsicano, G. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.006 · Cited by 152
Cannabinoids in pancreatic cancer: Correlation with survival and pain
Michalski, C. W., Oti, F. E., Erkan, M., Sauliunaite, D., Bergmann, F., Pacher, P., Bátkai, S., Müller, M. W., Giese, N. A., Frieß, H., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.23114 · Cited by 151
Cippitelli, A., Bilbao, A., Hansson, A. C., Del Arco, I., Sommer, W., Heilig, M., Massi, M., Bermúdez‐Silva, F. J., Navarro, M., Ciccocioppo, R., et al. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04056.x · Cited by 141
Ceramide: a new second messenger of cannabinoid action
Guzmán, M., Galve‐Roperh, I., & Sánchez, C. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01586-8 · Cited by 161
McLaughlin, R. J., Hill, M. N., & Gorzalka, B. B. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.006 · Cited by 157
Schalk‐Hihi, C., Schubert, C., Alexander, R., Bayoumy, S. S., Clemente, J. C., Deckman, I. C., DesJarlais, R. L., Dzordzorme, K. C., Flores, C. M., Grasberger, B. L., et al. (2011) · Protein Science · doi:10.1002/pro.596 · Cited by 158
Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back
Almogi‐Hazan, O., & Or, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124448 · Cited by 158
Lin, S., Khanolkar, A. D., Fan, P., Goutopoulos, A., Qin, C., Papahadjis, D., & Makriyannis, A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970257g · Cited by 158
Cannabinoids Desensitize Capsaicin and Mustard Oil Responses in Sensory Neurons via TRPA1 Activation
Akopian, A. N., Ruparel, N. B., Patwardhan, A., & Hargreaves, K. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1565-06.2008 · Cited by 139
Effects of cannabinoid receptors on skeletal muscle oxidative pathways
Cavuoto, P., McAinch, A. J., Hatzinikolas, G., Cameron‐Smith, D., & Wittert, G. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.12.038 · Cited by 149
Anandamide modulates sleep and memory in rats
Murillo‐Rodríguez, E., Sánchez-Alavez, M., Navarro, L., Martínez-González, D., Drucker-Colín, R., & Prospero-Garcia, O. E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00969-x · Cited by 152
Paria, B. C., Deutsch, D. D., & Dey, S. K. (1996) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199610)45:2<183::aid-mrd11>3.0.co;2-2 · Cited by 141
Endocannabinoids in nervous system health and disease: the big picture in a nutshell
Skaper, S. D., & Di Marzo, V. (2012) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0313 · Cited by 134
Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy
Angelidi, A. M., Belanger, M. J., Kokkinos, A., Koliaki, C. C., & Mantzoros, C. S. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab034 · Cited by 128
Hirasawa, M., Schwab, Y., Natah, S., Hillard, C. J., Mackie, K., Sharkey, K. A., & Pittman, Q. J. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.066159 · Cited by 143
Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
Freedland, C. S., Poston, J. S., & Porrino, L. J. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00359-2 · Cited by 147
Acute and Non-acute Effects of Cannabis on Brain Functioning and Neuropsychological Performance
González, R. (2007) · Neuropsychology Review · doi:10.1007/s11065-007-9036-8 · Cited by 161
Pharmacological Effects of Cannabinoids on the Caco-2 Cell Culture Model of Intestinal Permeability
Alhamoruni, A., Lee, A. C., Wright, K. L., Larvin, M., & O’Sullivan, S. E. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.168237 · Cited by 141
Emerging Therapeutic Strategies for Obesity
Foster-Schubert, K. E., & Cummings, D. E. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0041 · Cited by 142
Cloning and sequencing of a cDNA encoding the mouse brain-type cannabinoid receptor protein
Chakrabarti, A., Onaivi, E. S., & Chaudhuri, G. (1995) · DNA sequence · doi:10.3109/10425179509020870 · Cited by 171
Basavarajappa, B. S., Cooper, T. B., & Hungund, B. L. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00175-9 · Cited by 139
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins
Oddi, S., Fezza, F., Pasquariello, N., D'Agostino, A., Catanzaro, G., Simone, C. D., Rapino, C., Finazzi‐Agrò, A., & Maccarrone, M. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.05.004 · Cited by 156
Hsieh, G. C., Pai, M., Chandran, P., Hooker, B. A., Zhu, C. Z., Salyers, A. K., Wensink, E. J., Zhan, C., Carroll, W. A., Dart, M. J., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01046.x · Cited by 139
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
Katia, B. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00006 · Cited by 130
Endocannabinoid system: Role in depression, reward and pain control (Review)
Huang, W.-J., Chen, W.-W., & Zhang, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5585 · Cited by 133
Differential Roles of CB1 and CB2 Cannabinoid Receptors in Mast Cells
Samson, M.-T., Small-Howard, A., Shimoda, L. M. N., Koblan-Huberson, M., Stokes, A. J., & Turner, H. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.4953 · Cited by 137
Eggerickx, D., Denef, J. F., Labbé, O., Hayashi, Y., Refetoff, S., Vassart, G., Parmentier, M., & Libert, F. (1995) · Biochemical Journal · doi:10.1042/bj3090837 · Cited by 139
Maejima, T., Ohno‐Shosaku, T., & Kano, M. (2001) · Neuroscience Research · doi:10.1016/s0168-0102(01)00241-3 · Cited by 157
A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide
McFarland, M. J., Porter, A. C., Rakhshan, F. R., Rawat, D. S., Gibbs, R. A., & Barker, E. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407250200 · Cited by 137
Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide
Day, T. A., Rakhshan, F., Deutsch, D. G., & Barker, E. L. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.6.1369 · Cited by 137
Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles
Jansen, E. M., Haycock, D. A., Ward, S. J., & Seybold, V. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)90428-c · Cited by 139
Kaplan, B. L. F., Springs, A. E. B., & Kaminski, N. E. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.06.022 · Cited by 143
Autoradiographic Study of Pre- and Postnatal Distribution of Cannabinoid Receptors in Human Brain
Biegon, A. R., & Kerman, I. A. (2001) · NeuroImage · doi:10.1006/nimg.2001.0939 · Cited by 147
Molecular biology of cannabinoid receptors
Lutz, B. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0342 · Cited by 166
Fride, E., Foox, A., Rosenberg, E., Faigenboim, M., Cohen, V., Barda, L., Blau, H., & Mechoulam, R. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01295-0 · Cited by 153
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
van Egmond, N., Straub, V. M., & van der Stelt, M. (2021) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-030220-112741 · Cited by 122
Gorriti, M. Á., de Fonseca, F. R., Navarro, M., & Palomo, T. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00851-6 · Cited by 156
Anandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytes
Joseph, J., Niggemann, B., Zaenker, K. S., & Entschladen, F. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0509-9 · Cited by 145
Barna, I., Zelena, D., Arszovszki, A. C., & Ledent, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.06.006 · Cited by 136
The role of cannabinoids in adult neurogenesis
Prenderville, J. A., Kelly, Á. M., & Downer, E. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13186 · Cited by 126
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Han, S., Thatte, J., Buzard, D. J., & Jones, R. M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4005626 · Cited by 157
Involvement of TRPV1 Channels in Energy Homeostasis
Christie, S., Wittert, G., Li, H., & Page, A. J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00420 · Cited by 144
Harrold, J. A., Elliott, J. C., King, P., Widdowson, P. S., & Williams, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03245-6 · Cited by 156
Cannabinoids for gastrointestinal diseases: potential therapeutic applications
Carlo, G. D., & Izzo, A. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.1.39 · Cited by 146
Snider, N. T., Walker, V. J., & Hollenberg, P. F. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.001081 · Cited by 153
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Alves, P., Amaral, C., Teixeira, N., & Correia-da-Silva, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104822 · Cited by 135
Heteromerization of GPR 55 and cannabinoid CB 2receptors modulates signalling
Balenga, N. A. B., Martínez‐Pinilla, E., Kargl, J., Schröder, R. J., Peinhaupt, M., Platzer, W., Bálint, Z., Zamarbide, M., Dopeso‐Reyes, I. G., Ricobaraza, A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12850 · Cited by 149
Cannabinoids: Medical implications
Schrot, R. J., & Hubbard, J. R. (2016) · Annals of Medicine · doi:10.3109/07853890.2016.1145794 · Cited by 153
da Silva, K. A. B. S., Paszcuk, A. F., Passos, G. F., da Silva, E. S., Bento, A. F., Meotti, F. C., & Calixto, J. Β. (2011) · Pain · doi:10.1016/j.pain.2011.04.005 · Cited by 148
Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and rats
Mansbach, R. S., Rovetti, C. C., Winston, E., & Lowe, J. A., III (1996) · Psychopharmacology · doi:10.1007/bf02247436 · Cited by 140
Control of synaptic function by endocannabinoid-mediated retrograde signaling
Kano, M. (2014) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.90.235 · Cited by 153
Nabilone Decreases Marijuana Withdrawal and a Laboratory Measure of Marijuana Relapse
Haney, M., Cooper, Z. D., Bedi, G., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.54 · Cited by 139
Katsuyama, S., Mizoguchi, H., Kuwahata, H., Komatsu, T., Nagaoka, K., Nakamura, H., Bagetta, G., Sakurada, T., & Sakurada, S. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00242.x · Cited by 146
Nephrotoxic Effects of Common and Emerging Drugs of Abuse
Pendergraft, W. F., Herlitz, L., Thornley‐Brown, D., Rosner, M. H., & Niles, J. L. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00360114 · Cited by 134
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
Mestre, L., Correa, F., Arévalo‐Martín, A., Molina‐Holgado, E., Valenti, M., Ortar, G., Di Marzo, V., & Guaza, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02979.x · Cited by 134
Cota, D. (2007) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.764 · Cited by 124
Fatty Acid Sulfonyl Fluorides Inhibit Anandamide Metabolism and Bind to the Cannabinoid Receptor
Deutsch, D. G., Lin, S., Hill, W. A. G., Morse, K. L., Salehani, D., Arreaza, G., Omeir, R. L., & Makriyannis, A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6072 · Cited by 146
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors
Akerman, S., Kaube, H., & Goadsby, P. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705896 · Cited by 146
Airway effects of marijuana, cocaine, and other inhaled illicit agents
Tashkin, D. P. (2001) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200103000-00001 · Cited by 153
The Endocannabinoid System and Energy Metabolism
Bellocchio, L., Cervino, C., Pasquali, R., & Pagotto, U. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01728.x · Cited by 161
Marijuana-based Drugs: Innovative Therapeutics or Designer Drugs of Abuse?
Seely, K. A., Prather, P. L., James, L. P., & Moran, J. H. (2011) · Molecular Interventions · doi:10.1124/mi.11.1.6 · Cited by 153
Biosynthesis and degradation of the endocannabinoid 2‐arachidonoylglycerol
Ueda, N., Tsuboi, K., Uyama, T., & Ohnishi, T. (2010) · BioFactors · doi:10.1002/biof.131 · Cited by 155
Biochemistry of the Endogenous Ligands of Cannabinoid Receptors
Di Marzo, V., & Deutsch, D. G. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0214 · Cited by 127
Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 Receptors
Shoemaker, J. L., Ruckle, M. B., Mayeux, P. R., & Prather, P. L. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.089474 · Cited by 151
Cannabinoid Receptor Localization in Brain: Relationship to Motor and Reward Systems
HERKENHAM, M. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb25953.x · Cited by 129
Condie, R., Herring, A., Koh, W. S., Lee, M., & Kaminski, N. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.13175 · Cited by 135
Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology
Marchese, A., George, S. R., Kolakowski, L. F., Lynch, K. R., & O’Dowd, B. F. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01366-8 · Cited by 156
Drugs of Abuse, Immune Modulation, and AIDS
Cabral, G. A. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9023-5 · Cited by 146
The cannabinoid receptor CB2 exerts antifibrotic effects in experimental dermal fibrosis
Akhmetshina, A., Dees, C., Busch, N., Beer, J., Sarter, K., Zwerina, J., Zimmer, A., Distler, O., Schett, G., & Distler, J. H. W. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24395 · Cited by 126
GPR55 – a putative “type 3” cannabinoid receptor in inflammation
Yang, H.-W., Zhou, J., & Lehmann, C. (2015) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2015-0080 · Cited by 146
Banister, S. D., & Connor, M. A. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_144 · Cited by 137
Correa, F., Mestre, L., Docagne, F., & Guaza, C. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706215 · Cited by 131
Rinaldi, M. L., Pialot, F., Congy, C., Redon, E., Barth, F., Bachy, A., Brelière, J.-C., Soubrié, P., & Fur, G. L. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00085-9 · Cited by 144
Farquhar-Smith, P. W., Jaggar, S. I., & Rice, A. S. C. (2002) · Pain · doi:10.1016/s0304-3959(01)00419-5 · Cited by 132
Seeking a mechanism of action for the novel anticonvulsant lacosamide
Errington, A. C., Coyne, L., Stöhr, T., Selve, N., & Lees, G. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.02.002 · Cited by 137
An endogenous cannabinoid tone attenuates cholera toxin-induced fluid accumulation in mice
Izzo, A. A., Capasso, F., Costagliola, A., Bisogno, T., Marsicano, G., Ligresti, A., Matias, I., Capasso, R., Pinto, L., Borrelli, F., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00892-8 · Cited by 140
Bisogno, T., Delton-v, I., Milone, A., Lagarde, M., & Marzo, V. D. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1410 · Cited by 146
Kaminski, N. E., Koh, W. S., Yang, K. H., Lee, M., & Kessler, F. K. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90588-6 · Cited by 138
Cannabis and the developing brain: Insights from behavior
Trezza, V., Cuomo, V., & Vanderschuren, L. J. M. J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.058 · Cited by 131
Zebrafish: a model for the study of addiction genetics
Klee, E. W., Schneider, H., Clark, K. J., Cousin, M. A., Ebbert, J. O., Hooten, W. M., Karpyak, V. M., Warner, D. O., & Ekker, S. C. (2011) · Human Genetics · doi:10.1007/s00439-011-1128-0 · Cited by 139
Zoratti, C., Kipmen‐Korgun, D., Osibow, K., Malli, R., & Graier, W. F. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705529 · Cited by 127
Zhu, P. J., & Lovinger, D. M. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1148-05.2005 · Cited by 125
Basavarajappa, B. S., Saito, M., Cooper, T. B., & Hungund, B. L. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00085-5 · Cited by 135
Endocannabinoid Transport Revisited
Nicolussi, S., & Gertsch, J. (2015) · Vitamins and hormones · doi:10.1016/bs.vh.2014.12.011 · Cited by 141
Luchicchi, A., & Pistis, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8299-0 · Cited by 143
Patricio, F., Morales-Andrade, A. A., Patricio-Martínez, A., & Limón, I. D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.595635 · Cited by 129
Pálóczi, J., Varga, Z. V., Hasko, G., & Pacher, P. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7144 · Cited by 132
Metadata
- Authors
- Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Lolait, Stephen J.
- Venue
- Nature
- Published
- 1990-08-09
- Volume
- 346
- Issue
- 6284
- Pages
- 561-564
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2075894678
- Cited by
- 5,011
- References
- 20
- Citations by year
- 2026: 47 · 2025: 84 · 2024: 105 · 2023: 141 · 2022: 129 · 2021: 205 · 2020: 185 · 2019: 171 · 2018: 153 · 2017: 169 · 2016: 172 · 2015: 176 · 2014: 184 · 2013: 190 · 2012: 200
- FWCI
- 53.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cannabinoid receptors, G protein-coupled receptors, cDNA cloning, receptor structure, adenylate cyclase inhibition, pertussis toxin sensitivity, cannabis, central nervous system effects, brain mRNA expression
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Base Sequence, Binding, Competitive, Cannabinoids, Cell Line, Cerebral Cortex, Cloning, Molecular, Colforsin, Kinetics, Molecular Sequence Data, Receptors, Drug, Transfection, Gene Library, Receptors, Cannabinoid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.